MED-X, INC.

What the company does

Med-X, Inc. focuses on developing, marketing, and distributing natural, eco-friendly products. Its product lines include Nature-Cide®, Thermal-Aid®, and Malibu Brands, addressing pest control and consumer wellness markets. It also operates The MJT Network®, an online media platform providing cannabis-related content and advertising opportunities.

Use of proceeds

The Registered Stockholders may, or may not, elect to sell shares of our common stock covered by this prospectus. To the extent any Registered Stockholder chooses to sell shares of our common stock covered by this prospectus, we will not receive any proceeds from any such sales of our common stock.

Underwriters

The completed effective-prospectus read stated no underwriters.

Extracted from S-1/A 0001477932-26-006714, filed Nov 5, 2026 and verified against that filing text.

Key risk factors

• Nasdaq listing approval

  “The Company expects to satisfy these requirements at the time of listing; however, there can be no assurance that its application will be approved.”

• Volatile direct-listing trading

  “Further, the listing of our common stock on Nasdaq, without a firm-commitment underwritten offering, is a novel method for commencing public trading in shares of our common stock and, consequently, the trading volume and price of shares of our common stock may be more volatile than if shares of our common stock were initially listed in connection with an initial public offering underwritten on a firm-commitment basis.”

• Limited market history

  “No public market for our common stock currently exists, and our shares of common stock have a limited history of trading in private transactions.”

• Listing is a condition to the offering

  “If our Nasdaq application is not approved or we otherwise determine that we will not be able to secure the listing of our common stock on Nasdaq, we will not complete this Direct Listing.”

• No assurance of future listing

  “No assurance can be given that our Nasdaq application will be approved and that our common stock will ever be listed on Nasdaq.”

• CEO voting control

  “As a result, our Chairman and CEO has the ability to control the outcome of matters requiring stockholder approval, including the election of directors, amendments to our certificate of incorporation and bylaws, and the approval of significant corporate transactions, such as mergers, consolidations, or the sale of substantially all of our assets.”

• Private-market prices may not predict public trading

  “Recent purchase prices of our common stock in private transactions may have little or no relation to the opening public price of our shares of common stock on Nasdaq or the subsequent trading price of our shares of common stock on Nasdaq.”

• Registration does not guarantee completion

  “If our listing application is not approved by Nasdaq, we will not be able to consummate the offering and we will terminate this Direct Listing.”